Interestingly, ACPA levels in serum of RA patients correlate with the frequency of citrullinated antigen-binding (ACPA-expressing) B cells in peripheral blood [4] and can reach levels similar to peak levels of protective antibody responses against recall antigens such as tetanus toxoid (TT) [1,2,5]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.